Group items tagged

The concept of patient engagement has gained significant momentum in recent years, particularly in clinical research. Patient engagement refers to the active involvement of patients and their families in the research process, intending to improve the relevance and impact of clinical research. Raising awareness amongst the public and within patient communities is only the first

The Pharmacists' Defence Association (PDA) has submitted a 17-page contribution to the commission on the future of pharmacy professional leadership and encourages pharmacists to engage in the overall discussion. The association wants to ensure that the voice of its members is heard in the discussions about the future of professional leadership, which has been initiated by the four government Chief Pharmaceutical Officers. The PDA has published its first formal contribution to the commission, in its response it raised concern on the current exercise is being rushed and a call for the review to be conducted in a more sensible timeframe, one which enables the engagement of the whole profession. It has urged on being supportive of the creation of a Royal College of Pharmacists to take custodianship of the training and education for pharmacists and to set the requisite standards, whilst still relying upon the profession's regulators to undertake the accreditation role.

The Community Pharmacy England Committee has adopted a new approach to engagement with sector by inviting all pharmacy owners to share their views on pharmacy's finances, pressures and capacity ahead of its meeting in July. It has sought views of pharmacists via short poll by Sunday (2 July) and will have a discussion on the poll results at the meeting before reporting back to the sector afterwards. The key focus for July Committee Meeting will be to make most of £645m for the community pharmacy sector, and also on the ongoing work to make the wider case for more investment in the sector. This new way of working follows association's rebrand on 30th May which signalled the start of its new approach to engagement to help them to build stronger relationships with pharmacy owners. The association hopes this new approach will help them better engage with members and listen to pharmacy's views better.

The new 'How to Involve and Engage Patients on Digital Health Tech Innovation' learning module has been created specifically to support the development and delivery of patient-centric technologies, at a time of critical digital transformation in the NHS. The foundation level module will be freely available at www.orcha-digitalhealthacademy.com and on the Health Education England NHS Learning Hub (learninghub.nhs.uk). No training previously exists on conducting effective patient and public involvement and engagement (PPIE), leading to wasted resource on unsuitable technologies at a time when the healthcare system simply cannot afford it. The module aims to educate innovators who are creating new technology, and the clinicians who are prescribing these solutions. Crucially, the module also provides valuable support to the 500 NHS clinicians who are on the Clinical Entrepreneur Programme. The module is an introduction to the first evidence-based framework for PPIE, launched by the University of Plymouth, the AHSN Network (the national voice of the 15 academic health science networks in England) and Boehringer Ingelheim UK & Ireland. It helps to fast-track learning for the EnACT principles described in the framework, outlining how to involve patients in product innovation and critical issues such as data privacy, intellectual property, inclusivity, reimbursement, useability, and recruitment of patients.

Are you looking for a Patient Engagement Platform in Clinical Trials? Visit Clinvigilant- A leading clinical trial solutions provider

The Royal Pharmaceutical Society (RPS) Director for Scotland, Clare Morrison will be joining NHS Scotland in January. Morrison has been appointed Director of Community Engagement at Healthcare Improvement Scotland. Paul Bennett, RPS CEO said: "Many people, particularly in Scotland, will know of Clare's passion for quality improvement and patient involvement in the co-design of services. This was demonstrated through her previous work on the development of Near Me, NHS Scotland's video consulting service, and its co-design with the public, patients, clinicians and NHS staff which gained international recognition from the Institute for Healthcare Improvement. "Therefore, this is an exciting opportunity for Clare to join Healthcare Improvement Scotland to take on a strategic leadership role in supporting effective community engagement across health and social care in Scotland. It also enables Clare to make even greater use of her training as an NHS Scotland Scottish Quality & Safety Fellow and we wish her every success in her new role.

After engaging with contractors and stakeholders of NHS Community Pharmacy, the pharmacy review steering group (RSG) is planning to put proposals to contractors' vote before Easter 2022. The group, made up of representatives from the Association of Independent Multiple Pharmacies, Company Chemists' Association and independent community pharmacy, was formed in late 2020 to explore the future of community pharmacy network support. After engagement with the sector, the RSG has defined the roles of the local and national representative bodies, considered the contractor decision-making process, and worked through analysis and suggestions on local representation. It is now focusing on national representation and support.

The National Pharmacy Association has announced the theme for this year's 'Ask Your Pharmacist Week' campaign - 'Meet Your Local Pharmacy Team'. The campaign, scheduled for October 30 to November 6, seeks to enhance awareness of pharmacy services and initiate dialogues with local stakeholders, highlighting the role and advantages of community pharmacy, the NPA said in a statement. NPA has organised an array of promotional activities, spanning window displays, social media engagements, partnerships with patient groups, radio and TV interviews, and visits to pharmacies by local dignitaries and politicians during the week. "AYP Week 2023 will acquaint individuals with the pharmacist's skill set and the broader community pharmacy workforce, showcasing their collaborative efforts in delivering a secure and efficient service, encompassing NHS clinical care," said Stephen Fishwick, NPA's Head of Communications. "As always, the NPA will furnish campaign resources for our members and other participants interested in engaging with this enduring initiative."

In a rapidly evolving and competitive landscape, the pharmaceutical industry faces unique challenges when it comes to marketing its products and services. With stringent regulations, complex target audiences, and a need for trust and credibility, pharma companies need to employ effective marketing strategies to stand out in the crowd. In this blog article, we will explore some key marketing strategies for the pharma industry that can help boost their visibility, engage their target audience, and drive business growth. UNDERSTANDING THE UNIQUE LANDSCAPE The pharma industry operates in a highly regulated environment, where compliance and ethical considerations play a crucial role. Before diving into marketing strategies, it is essential to have a deep understanding of the industry's dynamics and the target audience. Researching the market, identifying patient needs, and studying the competitive landscape are vital steps in developing an effective marketing plan. EMBRACING DIGITAL TRANSFORMATION Digital transformation has revolutionized marketing across industries, and the pharma sector is no exception. Embracing digital channels and technologies can significantly enhance the reach and impact of marketing efforts. Pharma companies can leverage social media platforms, create engaging content, and build online communities to connect with patients, healthcare professionals, and other stakeholders. Implementing robust digital marketing strategies allows for personalized messaging, real-time communication, and targeted campaigns that resonate with the target audience.

The Pharmaceutical Services Negotiating Committee on Tuesday (June 30) renamed itself as Community Pharmacy England, promising a "strengthened commitment" to champion and engage with the sector. "The name Community Pharmacy England better reflects the breadth of work that we do to both represent and support community pharmacies in England. We are their champion," the pharmacy negotiator said. Explaining that the rebranding exercise was in line with proposals put forward by the Review Steering Group (RSG), it said the rebrand was part of its Transforming Pharmacy Representation (TAPR) work and that it would signal the beginning of a "new engagement strategy" to build stronger relationships with pharmacy owners. "Becoming Community Pharmacy England is much more than a name change or a new logo, it is a driver for cultural change across our organisation. "Our members want us to be more authoritative, representative, and influential, and rebranding gives us a clearer and stronger voice, helping us to better speak out for community pharmacy."

NHS England and NHS Improvement (NHSE&I), in association with the Royal Pharmaceutical Society (RPS) and the Association of Pharmacy Technicians UK (APTUK), has published its first inclusive pharmacy practice (IPP) bulletin, with an overarching ambition "to make community pharmacy a more inclusive environment for all pharmacy professionals". The IPP programme will take practical steps to improve the awareness and understanding at all levels of different cultural beliefs and attitudes, according to the Pharmaceutical Services Negotiating Committee (PSNC). As a member of the IPP Improving Practice and Engagement Group, PSNC has contributed to this issue of the Bulletin, which focuses on how pharmacy professionals can help to reduce health inequalities via the detection and prevention of cardiovascular diseases. The IPP programme, of which the Bulletin forms a part, aims to engage with local communities to help improve their health and reduce inequalities in care - particularly among those from ethnically diverse and disadvantaged backgrounds.

Community pharmacy should be involved in key decisions in neighbourhoods and systems to help reduce workload and increase patient access, a roundtable organised by the National Pharmacy Association to discuss a recent review on primary care integration has concluded. The NPA said it would be sending the recently published report on the roundtable to local pharmaceutical committees (LPCs) and other local pharmacy leaders as a tool to help them engage with Integrated Care Systems (ICSs) which will become statutory bodies from July 1. The 'Fuller Stocktake: Community Pharmacy Roundtable' report, published on June 13 by the NPA, is based on a meeting hosted by the association on behalf of the NHS team running a key review of primary care integration, the so-called 'Fuller Stocktake'. NPA integration lead, Michael Lennox, said: "The NPA recognises the critical importance of our LPC network colleagues being there for contractors at the 42 local systems level and influencing to fulfil the laudable ambitions of the Fuller Report. "We ensured that community pharmacy voices were heard in the stocktake process and now that conversation needs to be amplified locally."

PSNC has urged community pharmacy contractors and LPCs to engage with their local MPs on the immense pressures that pharmacies are facing. The organisaiton has also published some new resources to help pharmacists in this regard. "PSNC is deeply aware of the funding crisis affecting the sector and is working hard to increase the pressure on [the] government to act now with an urgent funding uplift. This has included upping investment in influencing activities and working closely with LPCs to take united action," it said. PSNC has last month launched its Four Point Plan to safeguard the future of community pharmacy, setting out how pharmacy could be the solution to a number of problems if, and only if, it is properly funded, resourced and supported. As pressures continue to mount, further briefings now focus solely on the urgent need to resolve the funding squeeze in order to protect existing pharmacy services.

Health care personnels who engage in such drug abuse situations actually bring a bad reputation to their profession and to their society as well.

Health care personnels who engage in such drug abuse situations actually bring a bad reputation to their profession and to their society as well.

Wolf Shlagman is the CEO, Founder, and Chief Angel of Care Angel. He is a creative technologist, tinkerer, and visionary behind the success of the company.

Medicines and Healthcare products Regulatory Agency (MHRA) has urged the healthcare professionals to share their views on the consultation on 'how MHRA communicate with healthcare professionals to improve medicines and medical devices' safety'. Through this consultation the agency wants to review its approach to engagement with healthcare professionals to improve the safety of medicines and medical devices. "We want to ensure that healthcare professionals are receiving actionable information and guidance on safe use of medicines and medical devices that they can take into their working practice, providing timely advice to patients," said MHRA. "We need to improve the way we communicate with healthcare professionals. We want to hear from you to enable us to transform how we communicate with you and how we work together on our common goal of greater patient safety."

 Babies whose fathers engage positively with them when they are three months old behave better later in life, research suggests.

We all know that diets can be unhealthy. Indeed, taken to the extreme they can be downright dangerous. Even if you engage in what you may regards as a healthy diet the danger still remains that you can be off a diet and on a diet. This syndrome is known as "yo-yo dieting".

Manual wheelchair has two types: one with a collapsible frame and the other with a frame that is rigid. The one with a collapsible frame is called the folding wheelchair and it is easier to transport and store than the rigid-framed wheelchair. Because it has reinforcing struts as well as folding and locking mechanisms, the first is relatively heavier than the second. A car can be used to transport a folding wheelchair. It can be placed in the car's trunk instead of having to provide for special moving arrangements or use a bigger vehicle such as a van. The wheelchair that folds usually has an x-frame that makes it possible to fold it sideways. When not in use, it can be kept in a small area of space. When navigating on an uneven surface, the four wheels of the folding wheelchair remain on the ground because its flexible frame of the chair yields and bends to make up for the unevenness of the terrain. This makes it more stable on the uneven surface than the rigid framed chair. On the other hand, it is less stable on a hard floor surface. While making it easy to fold and transport the chair, the parts of the folding chair that can be removed and adjusted can get lost or worn down more easily. The requirement for more frequent repair and replacement of these parts makes the chair that can be folded more expensive to maintain. The wheelchair with a rigid frame can be kept in good condition more economically. The moving parts of the folding wheelchair make the chair's frame more flexible. This flexibility absorbs a significant portion of the force exerted to propel the chair. Thus, it is harder to control and push. Its relatively heavier weight adds to this difficulty, requiring more effort, as well as greater strength and dexterity, to propel and maneuver the wheelchair when compared to the rigid wheelchair. There are certain activities that are not appropriate for the user of a chair that can be folded to engage in. The desirable features of the folding

Heavy Duty Wheelchair There are many ways in which a person with disabilities and physical mobility issues can get from A to B in this day and age. But bay far the most common method of personal transportation is the humble wheel chair. They come in many different designs as well as sizes, with light, heavy or miedium weighted devices available for specific uses and to cater for the indidual needs of the user. So in this News we'll take a brief look at heavy duty wheelchairs and where they are needed most. This is not an in-depth look, but just an overview with a view to expanding upon this subject at a later date. Buy online Heavy Duty wheelchair for handicapped and disabled at lowest price and cheap cost in india from wheelchair india online shopping store of Heavy Duty wheelchair manufacturer, distributor, dealer and supplier of variety of Karma Heavy Duty wheelchair at low price in india for handicapped and disability product like Karma Heavy Duty Wheelchair. Durability Of course the obvious use for heavy duty wheelchairs are for those users who have become very overweight or obese. This often happens directly due to the lack of exercise that their conditions bring about as it is sometimes simply not possible to engage in any form of meaningful exercise depending upon the severity of the physical handicap suffered by the user. In this case, then a heavy chassis and running gear are needed to cope with the extra weight of the user so that they can still get about in safety and comfort that the more lightweight wheelchairs would not be able to fulfill sufficiently. Strengthening The additional bracing and strengthening that is needed for these types of chairs comes with the trade off that they are in themselves much heavier than regular or lightweight models and are therefore that much more difficult to push around. For this reason, the fitter and stronger helpers are required to assist for safety reasons. In some cases, when a wheelchair use